- Home
- DXST vs MIRA Comparison
DXST vs MIRA Comparison
Compare DXST & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXST
- MIRA
- Stock Information
- Founded
- DXST 2011
- MIRA 2020
- Country
- DXST China
- MIRA United States
- Employees
- DXST N/A
- MIRA N/A
- Industry
- DXST
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- DXST
- MIRA Health Care
- Exchange
- DXST NYSE
- MIRA Nasdaq
- Market Cap
- DXST 21.4M
- MIRA 18.4M
- IPO Year
- DXST 2025
- MIRA 2023
- Fundamental
- Price
- DXST $1.41
- MIRA $1.10
- Analyst Decision
- DXST
- MIRA Strong Buy
- Analyst Count
- DXST 0
- MIRA 2
- Target Price
- DXST N/A
- MIRA $14.00
- AVG Volume (30 Days)
- DXST 366.4K
- MIRA 226.5K
- Earning Date
- DXST 01-01-0001
- MIRA 03-31-2025
- Dividend Yield
- DXST N/A
- MIRA N/A
- EPS Growth
- DXST N/A
- MIRA N/A
- EPS
- DXST N/A
- MIRA N/A
- Revenue
- DXST $4,333,276.00
- MIRA N/A
- Revenue This Year
- DXST N/A
- MIRA N/A
- Revenue Next Year
- DXST N/A
- MIRA N/A
- P/E Ratio
- DXST N/A
- MIRA N/A
- Revenue Growth
- DXST N/A
- MIRA N/A
- 52 Week Low
- DXST $1.21
- MIRA $0.51
- 52 Week High
- DXST $5.74
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- DXST N/A
- MIRA 43.36
- Support Level
- DXST N/A
- MIRA $1.09
- Resistance Level
- DXST N/A
- MIRA $1.18
- Average True Range (ATR)
- DXST 0.00
- MIRA 0.06
- MACD
- DXST 0.00
- MIRA -0.00
- Stochastic Oscillator
- DXST 0.00
- MIRA 7.69
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.